RecruitingNot ApplicableNCT07239219

The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.

To Determine the Efficacy of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.


Sponsor

Ohio State University

Enrollment

300 participants

Start Date

Dec 31, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 0.05% Chlorhexidine Gluconate and Normal Saline for people with antibiotic, catheter infection, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER0.05% Chlorhexidine Gluconate

0.05% CHG is instilled into the bladder prior to trial of void.

OTHERNormal Saline

Bladder is back filled with normal saline.


Locations(1)

The Ohio State University

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07239219


Related Trials